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Abstract
Salmonella enterica serovar Typhimurium (STM) represents the prevalent cause of foodborne gastroenteritis in
Italy with the majority of isolates exhibiting multidrug resistance. A resistant pattern that includes ampicillin (A),
streptomycin (S), sulfonamide (Su), and tetracycline (T) (ASSuT) but lacks resistance to chloramphenicol (C) has
recently emerged in Italy among strains of STM and of its monophasic variant, S. enterica subspecies enterica
serovar S. 4,[5],12:i:–. With the aim to evaluate their clonal relationships, 553 strains of STM and S. 4,[5],12:i:–
with the ASSuT and ACSSuT resistance patterns isolated in Italy from human infections between 2003 and 2006
were characterized by pulsed-field gel electrophoresis (PFGE) according to the PulseNet-Europe protocol and
nomenclature. Among both the STM and S. 4,[5],12:i:– ASSuT strains, the predominant PFGE profile was
STYMXB.0079 (53.2–73.0% of strains, respectively), while the STM ACSSuT strains belonged to the STYMXB.0061
(37.2% of strains) and STYMXB.0067 (29.9% of strains). Bionumerics cluster analysis of the nonunique PFGE
profiles showed that more than 90% of ASSuT and ACSSuT-resistant strains were included in two distinct clusters
with a genetic homology of 73% each other, suggesting that the ASSuT-resistant strains belong to a same clonal
lineage different from that of the ACSSuT strains. Phage typing showed that 23% of the ASSuT STM strains were
not typeable and 22.3% were U302. The same phage types were observed among the ASSuT strains of S. 4,[5],12:i:–.
A different figure was observed for the ACSSuT strains: the STM isolates mostly belonged to DT104 (70.2%), while
none of the S. 4,[5],12:i:– strains belonged to this phage type. This study indicates that the tetra-resistant ASSuT
strains of STM and S. 4,[5],12:i:–, increasingly isolated in Italy, belong to a same clonal lineage and that the
S. 4,[5],12:i:– strains circulating in our country mainly derive from this STM clonal lineage.
Introduction
Salmonella enterica serovar Typhimurium (STM) is acommon cause of nontyphoidal salmonellosis worldwide
and represents the second most prevalent serovar isolated in
Europe, after Salmonella Enteritidis (European Food Safety
Authority, 2007; http:==www.ecdc.europa.eu=pdf=ECDC_
epi_report_2007.pdf). In Italy, since 2001, STM represents the
prevalent cause of human infections (Graziani et al., 2008) and
in 2006 it accounted for the 44.2% of all human Salmonella
isolates (Galetta et al., 2008).
The public health impact of STM infections is further in-
creased by the high rate of antimicrobial resistance associated
with this serovar (Rabatsky-Ehr et al., 2004). In particular, an
epidemic multidrug-resistant (MDR) clonal lineage of STM,
namely, DT104 phage type (Weill et al., 2006), has emerged in
Europe and the United States since the 1980s. STM DT104 is
characterized by a penta-resistant pattern including resistance
to ampicillin (A), chloramphenicol (C), streptomycin (S), sul-
fonamide (Su), and tetracycline (T) (ACSSuT).
Recently, strains of STM with a tetra-resistant pattern
ASSuT, with or without additional resistances, but lacking
resistance to chloramphenicol, have emerged in Italy (Busani
et al., 2004). While the frequency of the ACSSuT pattern
among the Italian human isolates of STM remained constant
over the years, the frequency of the tetra-resistant pattern
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increased from 7% in the period 1999–2001 to 34.1% in 2006,
when the penta-resistant strains accounted for 29.6% (Busani
et al., 2004; Graziani et al., 2008).
In Italy the tetra-resistant pattern is also prevalent (Barone
et al., 2008; Galetta et al., 2008) among human isolates belonging
to S. enterica subspecies serovar 4,[5],12:i:– (S. 4,[5],12:i:–), de-
fined as a monophasic variant of SalmonellaTyphimurium. This
serovar shares almost all antigenic factors with STM, but it
lacks the second-phase flagellar antigen encoded by the fljB
gene (Echeita et al., 2001; Zamperini et al., 2007).
The monophasic serovar has been associated with human
infections in some European countries since 1997 (Echeita
et al., 1999; Mossong et al., 2007; Meakins et al., 2008) and
represents the third most frequent serovar from human in-
fections in Italy since 2004 (Galetta et al., 2006, 2007, 2008).
STM and monophasic strains with the ASSuT pattern have
been frequently isolated from animal sources—in particular,
swine and product thereof (http:==www.izsvenezie.it=dnn=
Portals=0=salmonellosi=EnterVet%202006.pdf; Barone et al.,
2008; Romani et al., 2008). Both human and animal strains
usually did not belong to DT104 (Busani et al., 2004; Graziani
et al., 2008) and often did not react with any of the phages
included in the panel currently used for phage typing (Ander-
son et al., 1977). Owing to this feature, molecular typing appears
to be the best tool for subtyping these isolates, to investigate
their clonal relationships, to track their spread, and to better
understand their epidemiology. Among the molecular typing
techniques, pulsed-field gel electrophoresis (PFGE) has became
the reference method all over the world (Swaminathan et al.,
2001; http:==www.cdc.gov=pulsenet=; http:==www.pulsenet-
europe.org=); it is considered the gold standard for molecular
subtyping of Salmonella and has been shown to be highly ef-
fective in epidemiological studies conducted on different ser-
ovars of S. enterica (Harbottle et al., 2006; Herrero et al., 2006;
Michael et al., 2006).
This study was undertaken to characterize STM and
S. 4,[5],12:i:– strains with the ASSuT pattern isolated from
human infections in Italy during the period 2003–2006, with
the aim of evaluating their clonal origin and their relation-
ships with the ACSSuT strains of STM and S. 4,[5],12:i:– iso-
lated in the same period.
Materials and Methods
Bacterial strains
During the period from January 2003 to December 2006,
732 STM and 191 S. 4,[5],12:i:– epidemiologically unrelated
strains were received at the Istituto Superiore di Sanita` in the
framework of the National surveillance system for enteric
infections (http:==www.iss.it=ente). Serotyping of Salmonella
spp. isolates was performed by slide agglutination according
to Kauffmann-White scheme (Grimont and Weill, 2007).
Strains were definitively assigned to serovar Typhimurium or
S. 4,[5],12:i:– on the basis of the presence or the absence of the
fljB gene tested by PCR (Echeita et al., 2002).
Antimicrobial susceptibility testing
The strains, many of which described in previous studies
(Graziani et al., 2008), were tested for antimicrobial suscepti-
bility by the disk diffusion method (Clinical and Laboratory
Standards Institute, 2006). The antimicrobials tested included
the following antibiotic disks (Becton Dickinson) and con-
centrations (mg): nalidixic acid (Nx) 30, ampicillin (A) 10, ce-
fotaxime (Ctx) 30, ciprofloxacin (Cp) 5, chloramphenicol (C)
30, gentamicin (G) 10, kanamycin (K) 30, streptomycin (S) 10,
sulfonamides (Su) 300, tetracycline (T) 30, and trimethoprim–
sulfamethoxazole (SXT) 1.25=23.75, according to the Enter-net
reference panel (Threlfall et al., 2003). Escherichia coli ATCC
25922 was used as control strain in each experiment. Isolates
showing tetra-resistant (ASSuT) and penta-resistant (ACSSuT)
profiles, with or without additional resistances to other classes
of antimicrobials, were included in this study.
PFGE
Genetic relatedness was determined by PFGE analysis after
digestion of DNA with XbaI restriction enzyme (New England
Biolabs, Ipswich, MA) and according to Salmgene and Pul-
seNet standardized protocol (Peters et al., 2003; Ribot et al.,
2006). S. enterica serovar Braenderup H9812 was used as the
molecular size marker (Hunter et al., 2005). Dendrogram and
cluster analysis were performed using algorithms available
within the BioNumerics software package (v. 4.61; Applied
Maths, Sint-Martens-Latem, Belgium). The percent similarity
between different chromosomal fingerprints was scored by
the Dice coefficient. The unweighted pair group method with
arithmetic means, with a 1.00% tolerance limit and 1.00%
optimization, was used to obtained the dendrogram. DNA
profiles differing by one or more DNA fragments were con-
sidered as distinct patterns. Strains with a coefficient of sim-
ilarity 80% were considered as closely related genetically.
The locally analyzed profiles of the strains were uploaded
to the international database established at the Health Pro-
tection Agency (HPA; Colindale, London, United Kingdom),
compared with the profiles in the international database and
named, as agreed with the PulseNet Europe, with a six-letter
code followed by a four-digit numerical identifier, for example,
STYMXB.0006 (Lukinmaa et al., 2006; http:==www.cdc.gov=
pulsenet=index).
Phage typing
It was possible to carry out phage typing on a subset of
strains: 357 STM and 69 S. 4,[5],12:i:, randomly selected among
each PFGE profile. The strains were phage typed according to
the protocol reported by Anderson et al. (1977) using phage
dilutions and the interpretative guidelines kindly supplied by
the HPA, Colindale. Strains that reacted to phages but did not
conform to any defined pattern were classified as reacts but
does not conform, and those that did not react with any of the
typing phages were considered unable to be typed (DTNT).
Results
The main antimicrobial resistance patterns of the 732 STM
and 191 S. 4,[5],12:i:– strains collected through the surveil-
lance system between 2003 and 2006 are reported in Table 1.
The 553 STM and S. 4,[5],12:i:– strains showing the ASSuT
or ACSSuT patterns, with or without additional resistances,
were further characterized by PFGE and partly by phage
typing.
All of the isolates were typeable using PFGE. The results of
PFGE profile analysis for each of clusters containing more
than one isolate are shown in Fig. 1.
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All the profiles obtained are summarized in Table 2 ac-
cording to the resistance pattern. The 203 ASSuT STM strains
were categorized into 54 different PFGE profiles, 44 of which
corresponded to a single isolate and are indicated as ‘‘other’’ in
Table 2. The predominant profile was STYMXB.0079, which
accounted for 53.2% of the isolates, followed by STYMXB.0339
(9.8%) and STYMXB.0010 (4.4%).
The 137 ASSuT S. 4,[5],12:i:– isolates belonged to 17 different
profiles, 13 of which corresponded to a single isolate. The
STYMXB.0079 profile was prevalent also in this group of
strains (73%), followed as well by STYMXB.0010 (9.5%) and
STYMXB.0339 (5.8%).
The coefficients of similarity (F) of the predominant
STYMXB.0079 with the STYMXB.0339 and STYMXB.0010
profiles were 0.84 and 0.91, respectively (Fig. 1).
The STYMXB.0079 and STYMXB.0010 profiles were also
observed among the nine ACSSuT S. 4,[5],12:i:– isolates
examined. Conversely, the 204 penta-resistant STM iso-
lates mostly (67.1%) belonged to the STYMXB.0061 and
STYMXB.0067 profiles, which showed an F-value of 0.95. We
also observed 41 PFGE profiles among ACSSuT strains, 31 of
which were unique.
Overall, two large clusters with a genetic homology of 73%
were identified. Cluster A included 275 out of the 283 (97.2%)
ASSuT strains, while cluster B, included 169 out of the 179
(94.4%) ACSSuT isolates, regardless of STM or S. 4,[5],12:i:–
serovar. A close genetic relationship (F> 0.80) was observed
among the strains belonging to each cluster. The few excep-
tions included eight tetra-resistant strains with PFGE profiles
(STYMXB.0086, STYMXB.0051, and STYMXB.0058) grouping
in cluster B, and 10 penta-resistant strains with profiles
grouping in cluster A (STYMXB.0079, STYMXB.0010, and
STYMXB.0080).
Phage typing was performed for 357 STM and 69 S.
4,[5],12:i:–, including tetra-resistant and penta-resistant strains.
The ASSuT strains mainly belonged to DTNT or U302: 23% and
22.3% of STM strains, and 46% and 27.9% of S. 4,[5],12:i:–
strains, respectively. Conversely, most of the ACSSuT STM
strains (70.2%) belonged to DT104, as expected, while none of
the ACSSuT S. 4,[5],12:i:– belonged to this phage type.
The associations between PFGE profiles and phage types
are described in detail in Tables 3 and 4.
Discussion
Surveillance of Salmonella infections in Italy showed that,
since 2001, STM has become the most common serovar asso-
ciated with human infections, reaching 44.2% of the cases in
2006 (Graziani et al., 2005; Galetta et al., 2008). During the same
period, an increase in infections associated with S. 4,[5],12:i:–
has also been observed, with this serovar accounting for 5.4%
FIG. 1. Dendrogram generated by BioNumerics software showing the results of cluster analysis of 20, nonunique, pulsed-
field gel electrophoresis (PFGE) patterns described among tetra-resistant and penta-resistant Salmonella Typhimurium and
S. 4,[5],12:i:– strains. Similarity analysis was performed using the Dice coefficient (Opt: 1.00%; Tol: 1.00%), and clustering was
by unweighted pair group method with arithmetic means. Cluster A indicates the tetra-resistant isolates, and cluster B the
penta-resistant isolates. *PFGE profiles of tetra-resistant isolates grouping in cluster B. **PFGE profiles showed by both the
R-types.
Table 1. Antimicrobial Resistance Pattern
of Salmonella Typhimurium and S. 4,[5],12:i:– Strains
R-type
Salmonella
Typhimurium n (%)
S. 4,[5],12:i:–
n (%)
ASSuT other 203 (27.7%) 137 (71.7%)
ACSSuT other 204 (27.9%) 9 (4.7%)
1–3 resistances 161 (22%) 27 (14.1%)
4 or þ resistances 42 (5.7%) 11 (5.7%)
Susceptible 122 (16.7%) 7 (3.7%)
Total 732 191
ASSuT: ampicillin (A), streptomycin (S), sulfonamide (Su), and
tetracycline (T); ACSSuT: ampicillin (A), chloramphenicol (C),
streptomycin (S), sulfonamide (Su), and tetracycline (T).
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of human salmonellosis in 2006 and ranking third after STM
and S. Enteritidis (Galetta et al., 2008).
As in other countries (Rabatsky-Ehr et al., 2004; Weill et al.,
2006; Meakins et al., 2008), the strains of STM and S. 4,[5],
12:i:– isolated in Italy are frequently MDR (Barone et al., 2008;
Graziani et al., 2008; this study). However, while the DT104-
associated ACSSuT pattern has been prevalently reported in
other countries, the STM strains isolated in Italy presented
either the ACSSuT pattern or an emerging ASSuT pattern
(Graziani et al., 2008). This pattern was also largely prevalent
among the S. 4,[5],12:i:– isolates that only rarely showed the
ACSSuT pattern (Barone et al., 2008; this study).
In the present study, PFGE typing of a representative
number of STM and S. 4,[5],12:i:– ASSuT strains isolated in
Italy during the last 4 years showed a strong association be-
tween this resistance pattern and particular PFGE profiles. In
particular, 67.5% of the ASSuT strains of STM belonged to the
prevalent PFGE profile STYMXB.0079 (53.2%) and, to a lesser
Table 2. Distribution of PFGE Profiles Among Tetra-R and Penta-R Salmonella
Typhimurium and S. 4,[5],12:i:– Strains
Salmonella Typhimurium S. 4,[5],12:i:–
PFGE profile (clustera) ASSuT other ACSSuT other ASSuT other ACSSuT other
STMXB.0079 (A) 108 (53.2) 5 (2.5) 100 (73) 3 (33.3)
STMXB.0339 (A) 20 (9.8) — 8 (5.8) —
STMXB.0010 (A) 9 (4.4) — 13 (9.5) 1 (11.1)
STMXB.0132 (A) 5 (2.5) — — —
STMXB.0022 (A) 4 (2) — — —
STMXB.0083 (A) 4 (2) — — —
STMXB.0080 (A) 1 (0.5) — 3 (2.2) 1 (11.1)
STMXB.0061 (B) — 76 (37.2) — 1 (11.1)
STMXB.0067 (B) — 61 (29.9) — —
STMXB.0114 (B) — 6 (2.9) — —
STMXB.0179 (B) — 5 (2.4) — —
STMXB.0020 (B) — 4 (2.0) — —
STMXB.0015 (B) — 4 (2.0) — —
STMXB.0260 (B) — 3 (1.5) — —
STMXB.0013 (B) — 2 (1.0) — —
STMXB.0115 (B) — 2 (1.0) — —
STMXB.0233 (B) — 2 (1.0) — —
STMXB.0058 (B) 3 (1.5) 3 (1.5) — —
STMXB.0086 (B) 3 (1.5) — — —
STMXB.0051 (B) 2 (0.9) — — —
Other profiles 44 (21.7) 31 (15.1) 13 (9.5) 3 (33.3)
Total 203 (100.0) 204 (100.0) 137 (100.0) 9 (100.0)
aClusters A and B were defined by Bionumeric cluster analysis as shown in Fig. 1.
PFGE, pulsed-field gel electrophoresis.
Table 3. Association Between PFGE Profile and Phage Types of the 357 Salmonella
Typhimurium Strains According to Resistance Pattern
Phage type
PFGE profile
ASSuT other ACSSuT other
STMXB.0079 STMXB.0339 STMXB.0010 Other STMXB.0061 STMXB.0067 STMXB.0079 Other
DTNT 27 3 — 9 2 — 2 5
U302 27 1 1 9 4 4 2 5
DT7 15 — — 6 — — — —
RDNC 3 2 — 9 — — — 7
DT120 7 — 6 9 2 2 — 11
DT20 3 — — — — — — —
DT194 2 — — 2 — — — —
DT104 — — — 4 54 45 — 32
DT193 — — — 8 — — — —
DT22 — 7 — — — — — —
Other 1 3 — 6 — — — 10
Total 85 16 7 62 62 51 4 70
DTNT, unable to be typed; RDNC, reacts does not conform.
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extent, to the two closely related profiles, STYMXB.0010
(4.4%) and STYMXB.0339 (9.8%). Similar percentages were
observed for S. 4,[5],12:i:– serovar; 88.3% of ASSuT strains
belonged to STYMXB.0079 (73%), STYMXB.0010 (9.5%), and
STYMXB.0339 (5.8%). These PFGE profiles were also ob-
served among the ACSSuT S. 4,[5],12:i:– strains, but not
among the STM penta-resistant isolates, 67.1% of which be-
longed to STYMXB.0061 (37.2%) and STYMXB.0067 (29.9%).
In general, the cluster analysis also showed that more than
90% of the penta-resistant and tetra-resistant strains were
included in two distinct clusters, suggesting that the ASSuT
strains belong to a same clonal lineage, different from that of
the ACSSuT strains.
A few of the STM and S. 4,[5],12:i:– strains with the
STYMXB.0079 profile showed the penta-resistant pattern, but
none of them belonged to DT104. Moreover, some of these
strains were negative for the presence of Salmonella Genomic
Island 1 when tested in a previous study by Amar et al. (2008).
These findings suggest that they could derive from the ASSuT
clonal lineage by the acquisition of resistance to chloram-
phenicol. On the contrary, the eight tetra-resistant strains
grouping in cluster B could harbor a defective Salmonella
Genomic Island 1 that may have lost the gene encoding for
chloramphenicol-florphenicol resistance (Boyd et al., 2002;
Carattoli et al., 2002).
The emergence and spread of the ASSuT clonal lineage,
herein described, deserves consideration. The isolation of
ASSuT STM strains has been reported in other countries, but
with lower prevalences and different strain characteristics. In
Denmark, ASSuT strains represented 10.2% of all the STM
isolated in 2003, and an ASSuT STM strain belonging to phage
type U302 was responsible for a prolonged outbreak in the
same year (Ethelberg et al., 2004). In France, a 3.8% prevalence
of ASSuT has been reported among STM strains isolated from
1993 to 2003, with different combinations of phage types and
PFGE types (Weill et al., 2006).
Differently from the Italian isolates, the ASSuT pattern has
been frequently associated with phage type DT193 in several
studies. In the United Kingdom, an ASSuT strain of STM
DT193 was responsible for an extensive outbreak in 1989; in
the following years the ASSuT pattern was detected in 38% of
STM DT193 isolates from human infections (Hampton et al.,
1995). The ASSuT pattern was reported in 14.2% of the STM
isolated in Spain between 2001 and 2003, with 40.5% of strains
being DT193 (Soler et al., 2006). In the United States, the
ASSuT pattern with additional resistance to kanamycin was
found to be common among STM isolated from swine during
1997–2000 (Gebreyes and Altier, 2002). Again, most of the
isolates belonged to phage type DT193 and showed a high
genetic homology. In the United States, the tetra-resistant
pattern with additional resistance to kanamycin was also
observed in 9% of the human strains isolated during 1997–
1998 (Rabatsky-Ehr et al., 2004). In that study, 36% of the
isolates were DTNT but, as stated by the authors, DT193 could
not be excluded, as the typing panel used did not include the
additional phages. In the present study, only 8 out of the 170
tetra-resistant STM strains examined belonged to phage type
DT193, and none of them belonged to STYMXB.0079 or clo-
sely related PFGE profiles. As far as S. 4,[5],12:i:– is concerned,
several studies have reported that MDR isolates mainly
present the ACSSuT pattern and belonged to the DT104
complex and clonal lineage (Echeita et al., 2001; de la Torre
et al., 2003; Amavisit et al., 2005). However, a strain of
S. 4,[5],12:i:– with the ASSuT pattern associated with an out-
break in Luxembourg belonged to phage type DT193 and
showed an STYMXB.0031 PFGE profile, according to Pulsenet
Europe nomenclature (Mossong et al., 2007).
Conclusions
This study indicates that the tetra-resistant ASSuT strains of
STM and S. 4,[5],12:i:–, increasingly isolated in Italy, belong to
a same clonal lineage and that the S. 4,[5],12:i:– strains circu-
lating in our country mainly derive from this STM clonal
lineage.
The results of this study show that S. 4,[5],12:i:– strains
isolated in Italy are mainly ASSuT and that the rare ACSSuT
strains do not belong to the DT104 clonal lineage.
Further studies are needed to characterize the resistance
genes present in the tetra-resistant ASSuT isolates and their
location. Aimed surveillance efforts will also be needed to
better understand the epidemiology of this MDR clone and its
potential for international spreading.
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